Hudson Bay Capital Management »

Hemab Therapeutics Holdings shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $448k 12k 36.73

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Sandisk Corp Put Option (SNDK)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Netflix Call Option (NFLX)
Apple Call Option (AAPL)
Echostar Corp Note 3.875%11/3 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
FMR
Capital Research and Management Company - Division 3
Deep Track Capital
Siren
venBio Select Advisor
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Driehaus Capital Management
Rock Springs Capital Management
Bellevue Group
Citadel Advisors
BlackRock

View all funds holding Hemab Therapeutics Holdings